Interestingly, MSR1 has been previously shown to promote tumour progression and metastasis in ovarian and pancreatic cancer mouse models (Neyen et al, 2013), suggesting that MSR1 and downstream signalling may be a potential drug target in the prevention of cancer metastasis progression. Here, MSR1 is linked to familial pancreatic carcinoma.